Search Results - Fengling Mi

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
    Survey of tuberculosis hospitals in China: current status and challenges.

    Survey of tuberculosis hospitals in China: current status and challenges. by Jian Du, Yu Pang, Yuhong Liu, Fengling Mi, Shaofa Xu, Liang Li

    Published 2014-01-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Tuberculosis Hospitalization Fees and Bed Utilization in China from 1999 to 2009: The Results of a National Survey of Tuberculosis Specialized Hospitals.

    Tuberculosis Hospitalization Fees and Bed Utilization in China from 1999 to 2009: The Results of a National Survey of Tuberculosis Specialized Hospitals. by Jian Du, Dirlikov Emilio, Yu Pang, Yan Ma, Fengling Mi, Yuhong Liu, Liang Li

    Published 2015-01-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Is resistance to anti-tuberculosis drugs associated with type 2 diabetes mellitus? A register review in Beijing, China

    Is resistance to anti-tuberculosis drugs associated with type 2 diabetes mellitus? A register review in Beijing, China by Fengling Mi, Guanglu Jiang, Jian Du, Liang Li, Wentao Yue, Anthony D. Harries, Sven Gudmund Hinderaker, Yan Lin

    Published 2014-05-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Efficacy of ultra-short course chemotherapy for new smear positive drug susceptible pulmonary tuberculosis: study protocol of a multicenter randomized controlled clinical trial

    Efficacy of ultra-short course chemotherapy for new smear positive drug susceptible pulmonary tuberculosis: study protocol of a multicenter randomized controlled clinical trial by Mengqiu Gao, Jingtao Gao, Jian Du, Yuhong Liu, Yao Zhang, Liping Ma, Fengling Mi, Liang Li, Shenjie Tang, on behalf of the Trial Team

    Published 2017-06-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Nine months of bedaquiline, linezolid, levofloxacin, clofazimine, and cycloserine chemotherapy for rifampicin/multidrug-resistant tuberculosis: a multicenter, randomized, open-label non-inferiority trial in China

    Nine months of bedaquiline, linezolid, levofloxacin, clofazimine, and cycloserine chemotherapy for rifampicin/multidrug-resistant tuberculosis: a multicenter, randomized, open-labe... by Yanhua Song, Wei Shu, Yi Pei, Juan Du, Guihui Wu, Hua Wang, Fengling Mi, Fangchao Liu, Liping Ma, Li Xie, Zhongshun Kong, Xiaoguang Wu, Rongmei Liu, Hongmei Chen, Hua Li, Qiping Ge, Lihui Nie, Zizheng Lv, Xuerui Huang, Mingwu Li, Mingying Jiang, Xiaohong Chen, Qingshan Cai, Wei Chen, Yanmei Liu, Yanfang Miao, Yan Tang, Yu Chen, Shujun Geng, Quanying Zhou, Yuhong Liu, Yu Pang, Mengqiu Gao

    Published 2024-09-01
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Correction: Nine months of bedaquiline, linezolid, levofloxacin, clofazimine, and cycloserine chemotherapy for rifampicin/multidrug-resistant tuberculosis: a multicenter, randomized, open-label non-inferiority trial in China

    Correction: Nine months of bedaquiline, linezolid, levofloxacin, clofazimine, and cycloserine chemotherapy for rifampicin/multidrug-resistant tuberculosis: a multicenter, randomize... by Yanhua Song, Wei Shu, Yi Pei, Juan Du, Guihui Wu, Hua Wang, Fengling Mi, Fangchao Liu, Liping Ma, Li Xie, Zhongshun Kong, Xiaoguang Wu, Rongmei Liu, Hongmei Chen, Hua Li, Qiping Ge, Lihui Nie, Zizheng Lv, Xuerui Huang, Mingwu Li, Mingying Jiang, Xiaohong Chen, Qingshan Cai, Wei Chen, Yanmei Liu, Yanfang Miao, Yan Tang, Yu Chen, Shujun Geng, Quanying Zhou, Yuhong Liu, Yu Pang, Mengqiu Gao

    Published 2024-10-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: